399 results  1 of 20 

1 The development of hepatocellular carcinoma during long-term treatment for recurrent non-small cell lung cancer: a case report
Seong Kyun Na, Seong Hee Kang
J Liver Cancer.2023;23(1):230-234.   Published online 2023 March 27     DOI: http://dx.doi.org/10.17998/jlc.2023.03.03
      
2 Predictors of Post-chemoradiotherapy Pulmonary Complication in Locally Advanced Non–Small Cell Lung Cancer
Tae Hoon Lee, Byung-Hee Kang, Hak Jae Kim, Hong-Gyun Wu, Joo Ho Lee
Cancer Res Treat.2023;55(3):865-874.   Published online 2023 January 19     DOI: http://dx.doi.org/10.4143/crt.2022.1538
      
3 The Incidence and Risk Factors of Chronic Pulmonary Infection after Radiotherapy in Patients with Lung Cancer
Yeonseok Choi, Jae Myoung Noh, Sun Hye Shin, Kyungjong Lee, Sang-Won Um, Hojoong Kim, Hongryull Pyo, Yong Chan Ahn, Byeong-Ho Jeong
Cancer Res Treat.2023;55(3):804-813.   Published online 2023 January 3     DOI: http://dx.doi.org/10.4143/crt.2022.1305
      
4 Effect of total intravenous versus inhalation anesthesia on long-term oncological outcomes in patients undergoing curative resection for early-stage non-small cell lung cancer: a retrospective cohort study
Kwon Hui Seo, Ji Hyung Hong, Mi Hyoung Moon, Wonjung Hwang, Sea-Won Lee, Jin Young Chon, Hyejin Kwon, Sook Hee Hong, Sukil Kim
Korean J Anesthesiol.2023;76(4):336-347.   Published online 2022 December 28     DOI: http://dx.doi.org/10.4097/kja.22584
      
5 Optimal Definition of Oligometastasis Showing Survival Benefits of Local Therapies during Tyrosine Kinase Inhibitor Treatment
Yoon Jung Jang, Dong-gon Hyun, Wonjun Ji, Chang-Min Choi, Shinkyo Yoon, Dae Ho Lee, Sang-We Kim, Jae Cheol Lee
Cancer Res Treat.2022;55(2):468-478.   Published online 2022 November 28     DOI: http://dx.doi.org/10.4143/crt.2022.1342
      
6 Biomarker testing of cytology specimens in personalized medicine for lung cancer patients
Hyojin Kim, Jin-Haeng Chung
J Pathol Transl Med.2022;56(6):326-333.   Published online 2022 November 9     DOI: http://dx.doi.org/10.4132/jptm.2022.10.17
      
7 Real World Characteristics and Clinical Outcomes of HER2-Mutant Non–Small Cell Lung Cancer Patients Detected by Next-Generation Sequencing
Beung-Chul Ahn, Ye-Jeong Han, Hye Ryun Kim, Min Hee Hong, Byoung Chul Cho, Sun Min Lim
Cancer Res Treat.2023;55(2):488-497.   Published online 2022 November 9     DOI: http://dx.doi.org/10.4143/crt.2022.359
      
8 The Additive Impact of Transbronchial Cryobiopsy Using a 1.1-mm Diameter Cryoprobe on Conventional Biopsy for Peripheral Lung Nodules
Soo Han Kim, Jeongha Mok, Eun-Jung Jo, Mi-Hyun Kim, Kwangha Lee, Ki Uk Kim, Hye-Kyung Park, Min Ki Lee, Jung Seop Eom
Cancer Res Treat.2022;55(2):506-512.   Published online 2022 November 1     DOI: http://dx.doi.org/10.4143/crt.2022.1008
      
9 Epidemiologic study of epidural analgesia for lung cancer surgery from 2011 to 2018 in South Korea: a National Health Insurance Database cohort study
Tak Kyu Oh, In-Ae Song
Korean J Anesthesiol.2022;75(5):407-415.   Published online 2022 July 15     DOI: http://dx.doi.org/10.4097/kja.22089
      
10 Five-Year Overall Survival and Prognostic Factors in Patients with Lung Cancer: Results from the Korean Association of Lung Cancer Registry (KALC-R) 2015
Da Som Jeon, Ho Cheol Kim, Se Hee Kim, Tae-Jung Kim, Hong Kwan Kim, Mi Hyung Moon, Kyongmin Sarah Beck, Yang-Gun Suh, Changhoon Song, Jin Seok Ahn, Jeong Eun Lee, Jeong Uk Lim, Jae Hyun Jeon, Kyu-Won Jung, Chi Young Jung, Jeong Su Cho, Yoo-Duk Choi, Seung-Sik Hwang, Chang-Min Choi
Cancer Res Treat.2023;55(1):103-111.   Published online 2022 June 20     DOI: http://dx.doi.org/10.4143/crt.2022.264
      
11 Challenges in the Use of Targeted Therapies in Non–Small Cell Lung Cancer
Joel Rivera-Concepcion, Dipesh Uprety, Alex A. Adjei
Cancer Res Treat.2022;54(2):315-329.   Published online 2022 February 18     DOI: http://dx.doi.org/10.4143/crt.2022.078
      
12 Long-term Exposure to PM10 Increases Lung Cancer Risks: A Cohort Analysis
Hyun Woo Lee, Sung-Chan Kang, Sun-Young Kim, Young-Jae Cho, Seungsik Hwang
Cancer Res Treat.2022;54(4):1030-1037.   Published online 2022 January 17     DOI: http://dx.doi.org/10.4143/crt.2021.1030
      
13 The Role of Neutrophil-to-Lymphocyte Ratio in Predicting Pathological Response for Resectable Non–Small Cell Lung Cancer Treated with Neoadjuvant Chemotherapy Combined with PD-1 Checkpoint Inhibitors
Xiaoyan Sun, Yingnan Feng, Bin Zhang, Wuhao Huang, Xiaoliang Zhao, Hua Zhang, Dongsheng Yue, Changli Wang
Cancer Res Treat.2022;54(4):1017-1029.   Published online 2021 November 23     DOI: http://dx.doi.org/10.4143/crt.2021.1007
      
14 Programmed death-ligand 1 expression and tumor-infiltrating lymphocytes in non-small cell lung cancer: association with clinicopathologic parameters
Gaurav Garg, Kuruswamy Thurai Prasad, Navneet Singh, Parul Gupta, Valliappan Muthu, Ashim Das, Amanjit Bal
J Pathol Transl Med.2021;55(6):398-405.   Published online 2021 October 6     DOI: http://dx.doi.org/10.4132/jptm.2021.08.08
      
15 Predictive Value of Interstitial Lung Abnormalities for Postoperative Pulmonary Complications in Elderly Patients with Early-Stage Lung Cancer
Won Gi Jeong, Yun-Hyeon Kim, Jong Eun Lee, In-Jae Oh, Sang Yun Song, Kum Ju Chae, Hye Mi Park
Cancer Res Treat.2022;54(3):744-752.   Published online 2021 September 28     DOI: http://dx.doi.org/10.4143/crt.2021.772
      
16 Cost Utility Analysis of a Pilot Study for the Korean Lung Cancer Screening Project
Juyoung Kim, Bogeum Cho, Seon-Ha Kim, Chang-Min Choi, Yeol Kim, Min-Woo Jo
Cancer Res Treat.2022;54(3):728-736.   Published online 2021 September 24     DOI: http://dx.doi.org/10.4143/crt.2021.480
      
17 Histologic Changes in Non–Small Cell Lung Cancer under Various Treatments: A Comparison of Histology and Mutation Status in Serial Samples
Chang Gok Woo, Seung-Myoung Son, Ho-Chang Lee, Hye Sook Han, Ki Hyeong Lee, Dohun Kim, Eung-Gook Kim, Ok-Jun Lee
Cancer Res Treat.2022;54(3):737-743.   Published online 2021 September 24     DOI: http://dx.doi.org/10.4143/crt.2021.773
      
18 Robust home brew fragment sizing assay for detection of MET exon 14 skipping mutation in non–small cell lung cancer patients in resource constrained community hospitals
Anurag Mehta, Shrinidhi Nathany, Aanchal Chopra, Sakshi Mattoo, Dushyant Kumar, Manoj Kumar Panigrahi
J Pathol Transl Med.2021;55(5):324-329.   Published online 2021 September 2     DOI: http://dx.doi.org/10.4132/jptm.2021.07.15
      
19 The Clinical Outcomes of Different First-Line EGFR-TKIs Plus Bevacizumab in Advanced EGFR-Mutant Lung Adenocarcinoma
Yen-Hsiang Huang, Kuo-Hsuan Hsu, Chun-Shih Chin, Jeng-Sen Tseng, Tsung-Ying Yang, Kun-Chieh Chen, Kang-Yi Su, Sung-Liang Yu, Jeremy J.W. Chen, Gee-Chen Chang
Cancer Res Treat.2022;54(2):434-444.   Published online 2021 August 2     DOI: http://dx.doi.org/10.4143/crt.2021.671
      
20 Targeted Liquid Biopsy Using Irradiation to Facilitate the Release of Cell-Free DNA from a Spatially Aimed Tumor Tissue
Jae Myoung Noh, Yeon Jeong Kim, Ho Yun Lee, Changhoon Choi, Won-Gyun Ahn, Taeseob Lee, Hongryull Pyo, Jee Hyun Park, Donghyun Park, Woong-Yang Park
Cancer Res Treat.2022;54(1):40-53.   Published online 2021 May 25     DOI: http://dx.doi.org/10.4143/crt.2021.151
      

 1 of 20